Korea ‘Guide’ Program To Speed Select Innovative Products To Market
Part Of Regulatory Science Push
In an ongoing effort to accelerate the commercialization of select innovative drugs and medical devices, Korea’s MFDS is launching a new program for certain products that will receive regular regulatory consultations until they reach the approval stage.
